Illumina, Inc. (ILMN)

Healthcare
$164.63▲ 0.35 (0.21%)
Real-time prices · US Markets
📅
Next earnings: Jul 30
Neutral
6.8 / 10
High-quality business with 34% return on equity and 19% profit margins.
consensus analyst target is below current price.
Quality
8.5
Health
7.6
Growth
6.3
Valuation
4.8
Sentiment
6.1
Analyst Target
$147.17
10.6% from current

Price Chart

Fundamentals

Trailing P/E
29.9×
price-to-earnings
Forward P/E
27.8×
next 12 months est.
Market Cap
$24.9B
market capitalization
Div Yield
dividend yield
Profit Margin
19.4%
net profit margin
Gross Margin
68.3%
revenue minus COGS
ROE
33.8%
return on equity
Beta
1.49
vs S&P 500
52-Week Range
$88 — $177
annual min — max

EPS — Estimate vs Actual

Frequently Asked Questions

What do analysts say about Illumina, Inc. right now?
Illumina, Inc.'s Q·Score is 6.8/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 34% return on equity and 19% profit margins. Key area to monitor: consensus analyst target is below current price. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for ILMN?
The consensus price target for ILMN is $147.17, based on ratings from 18 Wall Street analysts. This is 10.6% below the current price of $164.63. Price targets are forward-looking estimates and not guarantees of future performance.
Is ILMN overvalued or undervalued?
Illumina, Inc. (ILMN) scores below peers on valuation metrics, trading above typical sector multiples. Its forward P/E ratio stands at 27.8×. The consensus analyst price target of $147.17 is 11% below the current price.
When does Illumina, Inc. report its next earnings?
Illumina, Inc.'s next earnings report is expected on approximately July 30, 2026.
What is Illumina, Inc.'s profit margin?
Illumina, Inc. has a net profit margin of 19.4%, which is solid for most industries. Its gross margin stands at 68.3%, indicating a high-margin business model.
Is Illumina, Inc.'s revenue growing?
Illumina, Inc. is reporting modest revenue growth of 4.8%. Earnings are also growing at 6.1%, indicating improving profitability.
How much debt does Illumina, Inc. have?
Illumina, Inc. has a debt-to-equity ratio of 0.95×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.75×, indicating comfortable short-term liquidity.
Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026